D
$ Value
$158K
Shares
5,214
Price
$30
Filed
Sep 15
Insider
Name
Kitayama Mitchell W
Title
—
CIK
0001333154
Roles
Director
Transaction Details
Transaction Date
2025-09-15
Code
D
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
15,846
Footnotes
These shares were repurchased by the Issuer. | These stock options were fully vested and exercisable. | Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Filing Info
Kitayama Mitchell W's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-07 | ASTH | M | $218K |
| 2025-11-07 | ASTH | M | $0 |
| 2025-09-15 | ASTH | M | $146K |
| 2025-09-15 | ASTH | D | $242K |
| 2025-09-15 | ASTH | D | $158K |
| 2025-09-15 | ASTH | M | $0 |
| 2025-06-11 | ASTH | A | $0 |
Other Insiders at ASTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lam Thomas S. | — | — | 2026-04-06 |
|
Sim Kenneth T.
Executive Chairman
|
— | — | 2026-04-06 |
|
Sim Brandon
CEO and President
|
— | — | 2026-04-06 |
|
Kumar Dinesh M.
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Sobotka Glenn
Chief Accounting Officer
|
— | — | 2026-03-26 |
|
Basho Chandan
COO and CFO
|
— | — | 2026-04-14 |